Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative Disorders

Smriti Gupta1, Savita Verma1, Shrikant Mantri2

  • 1Department of Biochemistry, Panjab University, Chandigarh, 160014, India.

Drug Development Research
|September 12, 2015
PubMed

Insights

MicroRNAs (miRNAs) regulate gene expression and are implicated in neurodegenerative disorders. Targeting specific miRNAs offers a promising therapeutic strategy for neurological conditions.

Area of Science:

  • Molecular Biology
  • Neuroscience
  • Genetics

Background:

  • MicroRNAs (miRNAs) are small noncoding RNAs regulating gene expression.
  • miRNAs are crucial in biological processes like neuronal development and disease.
  • Altered miRNA expression is linked to neurodegenerative disorders (NDDs).

Purpose of the Study:

  • To review the role of miRNAs in various NDDs.
  • To explore the potential of miRNA-targeted therapies for neurological conditions.

Main Methods:

  • Literature review of preclinical research on miRNAs in NDDs.
  • Analysis of the regulatory functions of specific miRNAs (e.g., miRNA 15, 21, 146a).

Main Results:

  • Specific miRNAs, including miRNA 15, 21, and 146a, play critical roles in NDDs.
  • miRNA-targeted approaches can simultaneously target multiple disease-related pathways.

Conclusions:

  • miRNAs are significant regulators in neurodegeneration.
  • miRNA-based therapeutics hold potential for preventing and treating neurological diseases.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K
MicroRNAs01:22

MicroRNAs

12.1K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
19.0K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K